Entry comments: I bought the pullback off the highs. The stock is lower on volume but it is squeezing and holding former levels well. The stock is up in sympathy with Genentech who has release very good Phase 3 breast cancer news.

Exit comments: I rode the price all the way to 28 but I got a little too greedy. and didn't sell any of my position. When the stock was consolidating, I sold half at 27 and let the rest ride. New risk was entry. As the stock was holding 26 pretty well, I decided to sell the remainder of my position when it cracked. The stock bounce again nicely to the 30's but had I held longer, I would have stopped out anyway. I played this one very well I think.